These considerations apply to sporadic breast cancer but may also provide insights into the mechanisms of high-penetrance susceptibility genes since risk variants at low-penetrance loci also contribute to the risk of BRCA1 and BRCA2 mutation carriers [87]. The gene discussed is BRCA2; the disease is breast carcinoma.